Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lignosus rhinocerus TM02
- Development stage
- Unknown
- Lead developer
- Lignobio
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
Lignosus rhinocerus TM02 (also known as Tiger Milk Mushroom) is a medicinal fungus native to Southeast Asia. The sclerotium (hardened fungal mycelium) contains bioactive compounds with anti-inflammatory, immunomodulatory, anti-tumor, and antihypertensive properties. It is traditionally used for treating asthma, bronchitis, cancer, and various other ailments. The TM02 cultivar is grown using food-based materials in a hygienic and controlled environment and harvested at optimum conditions.
- Brand names
- TM02TM-02TM 02
- Other names
- Tiger Milk Mushroom
02
Targets
NO2- (Nitrite)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Lignosus rhinocerus TM02.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lignosus rhinocerus TM02.